(Q46664766)

English

Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

0 references

1 reference

based on heuristic

inferred from title

author name string

Liqun Lv

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

Yi Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

Yongyu Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

Kan Tan

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

Journal of Huazhong University of Science and Technology. Medical Sciences

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

25

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

194-197

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FBF02873575

21 January 2018

Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin directly inhibits androgen production in human thecal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-lowering medications in polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic effects of oral contraceptives in women with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16116971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02873575

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116971

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46664766&oldid=2208007665"